CoChat

Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Mälestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.).

Kask, Ants, Mutulis, Felikss, Muceniece, Ruta, Pähkla, Rein, Mutule, Ilze, Wikberg, Jarl E. S., Rägo, Lembit, Schiöth, Helgi B. · 1998 · Endocrinology
Cited by 155

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Several novel cyclic MSH analogs were synthesized, and their binding properties were tested on cells transiently expressing the human melanocortin-1 (MC1), MC3, MC4, and MC5 receptors. We discovered a novel substance (HS024) that showed about 20-fold selectivity and very high affinity (Ki = 0.29 nM) for the MC4 receptor. HS024 (cyclic [AcCys3,Nle4,Arg5,D-Nal7,Cys-NH2(11)]alpha-MSH-(3-11)) has a 29-membered atom ring structure that includes an Arg in position 5. HS024 was found to antagonize an alphaMSH-induced cAMP response in cells expressing the human MC1, MC3, MC4, and MC5 receptor DNAs. HS024 also caused a dose-dependent increase in food intake, with a maximum response (4-fold increase) at a 1-nmol dose injected intracerebroventricularly in free feeding rats. We also tested SHU9119, a previously described nonselective MC receptor antagonist, and found HS024 and SHU9119 to have similar potencies for increasing food intake, although SHU9119 appeared to induce more serious side-effects. HS024 increased the food intake of free feeding rats to levels comparable to those in food-deprived rats, indicating that blockade of the MC4 receptor is a highly effective way to increase feeding. Moreover, we tested the effects of intracerebroventricular injections of HS024 in elevated plus-maze and open-field experiments on rats. In these tests, HS024 did not appear to affect emotionality or locomotor activity, suggesting that the MC4 receptor does not mediate the anxiogenic-like and locomotor effects related to the melanocortic peptides.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endo.139.12.6352

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 41

  1. Chhajlani, 1992, Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA., FEBS Lett, 309, 417, 10.1016/0014-5793(92)80820-7 · DOI · Paper page
  2. Gantz, 1993, Molecular cloning of a novel melanocortin receptor., J Biol Chem, 268, 8246, 10.1016/S0021-9258(18)53088-X · DOI · Paper page
  3. Gantz, 1993, Molecular cloning, expression, and gene localization of a fourth melanocortin receptor., J Biol Chem, 268, 15174, 10.1016/S0021-9258(18)82452-8 · DOI · Paper page
  4. Chhajlani, 1993, Molecular cloning of a novel human melanocortin receptor., Biochem Biophys Res Commun, 195, 866, 10.1006/bbrc.1993.2125 · DOI · Paper page
  5. Cone, 1996, The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation., Recent Prog Horm Res, 51, 287
  6. Roselli-Rehfuss, 1993, Identification of a receptor for melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system., Proc Natl Acad Sci USA, 90, 8856, 10.1073/pnas.90.19.8856 · DOI · Paper page
  7. Mountjoy, 1994, Localization of the melanocortin-4 receptor (MC4-R) in endocrine and autonomic control circuits in the brain., Mol Endocrinol, 8, 1298
  8. Chen, 1997, Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides., Cell, 91, 789, 10.1016/S0092-8674(00)80467-5 · DOI · Paper page
  9. Schiöth, 1995, Characterisation of melanocortin receptor subtypes by radioligand binding analysis., Eur J Pharmacol, 288, 311, 10.1016/0922-4106(95)90043-8 · DOI
  10. Schiöth, 1996, Characterisation of melanocortin 4 receptor by radioligand binding analysis., Pharmacol Toxicol, 79, 161, 10.1111/j.1600-0773.1996.tb00261.x · DOI · Paper page
  11. Schiöth, 1996, Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors., Life Sci, 59, 797, 10.1016/0024-3205(96)00370-0 · DOI · Paper page
  12. Hruby, 1995, Cyclic lactamα -melanotropin analogues of Ac-Nle4-cyclo(Asp5,d-Phe7,Lys10)α-melanocyte-stimulating hormone-(4–10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors., J Med Chem, 38, 3454, 10.1021/jm00018a005 · DOI · Paper page
  13. Schiöth, 1998, Discovery of novel melanocortin 4 receptor selective MSH analogues., Br J Pharmacol, 124, 75, 10.1038/sj.bjp.0701804 · DOI · Paper page
  14. Li, 1996, Melanocortin antagonists define two distinct pathways of cardiovascular control by α- andγ -melanocyte-stimulating hormones., J Neurosci, 16, 5182, 10.1523/JNEUROSCI.16-16-05182.1996 · DOI · Paper page
  15. Fan, 1997, Role of melanocortinergic neurons in feeding and the agouti obesity syndrome., Nature, 385, 165, 10.1038/385165a0 · DOI · Paper page
  16. Seeley, 1997, Melanocortin receptors in leptin effects., Nature, 390, 349, 10.1038/37016 · DOI · Paper page
  17. Kask, 1998, Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats., Biochem Biophys Res Commun, 245, 90, 10.1006/bbrc.1998.8389 · DOI
  18. Kask, 1998, Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y., Biochem Biophys Res Commun, 248, 245, 10.1006/bbrc.1998.8961 · DOI
  19. Tagliaferro, 1982, Spillage behavior and thiamin deficiency in the rat., Physiol Behav, 28, 933, 10.1016/0031-9384(82)90217-7 · doi:10.1016/0031-9384(82)90217-7
  20. Gonzales, 1996, Behavioral effects of α-MSH and MCH after central administration in the female rat., Peptides, 17, 171, 10.1016/0196-9781(95)02092-6 · DOI · Paper page
  21. Panksepp, 1990, Modulation of separation distress by α-MSH., Peptides, 11, 647, 10.1016/0196-9781(90)90174-4 · doi:10.1016/0196-9781(90)90174-4
  22. Panksepp, 1990, Effects of ACTH(1–24) and ACTH/MSH-(4–10) on isolation-induced distress vocalization in domestic chicks., Peptides, 11, 915, 10.1016/0196-9781(90)90009-T · doi:10.1016/0196-9781(90)90009-t
  23. Corda, 1990, Proconflict effect of ACTH1–24: interaction with benzodiazepines., Pharmacol Biochem Behav, 36, 631, 10.1016/0091-3057(90)90267-L · doi:10.1016/0091-3057(90)90267-l
  24. Sawyer, 1980, [Nle4,d-Phe7]a-melanocyte stimulating hormone: a highly potent α-melanotropin with ultralong biological activity., Proc Natl Acad Sci USA, 77, 5754, 10.1073/pnas.77.10.5754 · DOI · Paper page
  25. Nordstedt, 1990, A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid., Anal Chem, 189, 231
  26. Schiöth, 1997, Selectivity of cyclic [d-Phe7] and[ d-Nal7] substituted MSH analogues for the melanocortin receptors., Peptides, 18, 1009, 10.1016/S0196-9781(97)00079-X · DOI
  27. Kask, 1997, α-helical CRF9–41 prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats., Neuroreport, 8, 3645, 10.1097/00001756-199711100-00044 · DOI · Paper page
  28. Kask, 1998, Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13–36 microinjected into vicinity of locus coeruleus in rats., Brain Res, 788, 345, 10.1016/S0006-8993(98)00076-6 · DOI
  29. Broadhurst, 1975, The Maudsley reactive and nonreactive strains of rats: a survey., Behav Genet, 5, 299, 10.1007/BF01073201 · DOI · Paper page
  30. Knittel, 1983, Structure-activity studies of highly potent[ Cys4,Cys10]melanotropin analogues., J Med Chem, 28, 125, 10.1021/jm00356a002 · doi:10.1021/jm00356a002
  31. Sawyer, 1982, [half-Cys4, half-Cys10]-α-melanocyte stimulating hormone; a cyclic α-melanotropin exibiting superagonist biological activity., Proc Natl Acad Sci USA, 79, 1751, 10.1073/pnas.79.6.1751 · DOI · Paper page
  32. Al-Obeidi, 1989, Potent and prolonged acting cyclic lactam analogues ofα -melanotropin: design based on molecular dynamics., J Med Chem, 32, 2555, 10.1021/jm00132a010 · DOI · Paper page
  33. Schiöth, 1998, Selective properties of C- and N-terminals and core residues in the melanocortin stimulating hormone peptide for the melanocortin receptor subtypes., Eur J Pharmacol, 349, 359, 10.1016/S0014-2999(98)00212-X · DOI
  34. Jayawickreme, 1994, Discovery and structure-function analysis of a-melanocyte-stimulating hormone antagonists., J Biol Chem, 269, 29846, 10.1016/S0021-9258(18)43958-0 · DOI
  35. Quillan, 1996, Structure-based search for peptide ligands that cross-react with melanocortin receptors., Pharm Res, 13, 1624, 10.1023/A:1016424203457 · doi:10.1023/a:1016424203457
  36. Kask, 1998, Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226., Br J Pharmacol, 124, 1507, 10.1038/sj.bjp.0701969 · DOI · Paper page
  37. Morley, 1987, Effect of neuropeptide Y on ingestive behaviors in the rat, Am J Physiol, 252, R599
  38. Biro, 1993, Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats., Neuroendocrinology, 57, 340, 10.1159/000126377 · DOI · Paper page
  39. Heilig, 1988, Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction withα -adrenoceptors., Eur J Pharmacol, 157, 205, 10.1016/0014-2999(88)90384-6 · DOI
  40. Kim, 1997, Agouti regulation of intracellular calcium: role of melanocortin receptors, Am J Physiol, 272, E379
  41. Gross, 1993, A new experimental model of epilepsy based on the intraventricular injection of endothelin, J Cardiovasc Pharmacol, 22, S282, 10.1097/00005344-199322008-00074 · doi:10.1097/00005344-199322008-00074

Cited by

See all 155

Metadata

Authors
Kask, A., Mutulis, F., Muceniece, R., Pähkla, R., Mutule, I., Wikberg, J. E. S., Rägo, L., & Schiöth, H. B.
Venue
Endocrinology
Published
1998-12-01
Volume
139
Issue
12
Pages
5006-5014
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W1980392808
Cited by
155
References
7
FWCI
4.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Mälestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.). https://app.cochat.ai/papers/10.1210/endo.139.12.6352
The paper
Kask, A., Mutulis, F., Muceniece, R., Pähkla, R., Mutule, I., Wikberg, J. E. S., Rägo, L., & Schiöth, H. B. (1998). Discovery of a Novel Superpotent and Selective Melanocortin-4 Receptor Antagonist (HS024): Evaluation in Vitro and in Vivo**This work was supported by grants from the Swedish Medical Research Council (04X-05957), the Swedish Society for Medical Research, and the Estonian Science Foundation (Grant 3267); the Ants ja Maria Silvere ning Sigfried Panti Mälestusstipendium Foundation (to A.K.); and the Swedish Institute (to I.M.). Endocrinology. https://doi.org/10.1210/endo.139.12.6352

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.